Strong transformations have happened in recent years. Covid outbreak had a tremendous impact on our lives and our practices, encouraging and accelerating technological and social changes at many levels. Most obvious is of course teleworking and home delivery as response to lock down and travel restrictions, but it has also modified our perception of medical innovations that was already happening in healthcare, all looking after the same objective: avoid unnecessary visits to hospital and physicians to reduce occupation and face medical staff reduction.

Markets are already moving on with these technologies. United States before anyone else, followed by Europe and Asia Pacific region. This is directly linked to the fact these regions are facing an ageing population with the challenge related to chronic diseases, and an increased awareness of infectious diseases.

All-in-all, the benefits of the new wearable “smart-patches” are multiple and significant. Alix Joseph, New Ventures HealthCare Director at Linxens have listed 5 major benefits to both clinicians, patients and society:

1. Continuous monitoring: Unlocking easy continuous monitoring of various physiological parameters such as heartbeat, temperature or breathing (but not only), it provides a complete picture of patients’ vital signs, not only a snapshot.
2. Remote monitoring: Connected to smartphones or other devices, they allow patients to send data to healthcare providers remotely. This can help to identify problems early and improve the management of chronic conditions.
3. Early detection: Continuous monitoring allows for early detection of changes in patients’ health leads to early treatment and then better outcomes.
4. Personalized medicine: Monitoring and tracking individual patients’ health metrics, providing valuable information could be used to develop personalized treatment plans.
5. Cost-effective: Being disposable and less expensive than other traditional medical devices and lab tests, it makes them more accessible for patients and healthcare providers.

Linxens is working on the vertical integration of the different pieces in these wearable medical devices to ensure the easier and faster development, focusing on robust and reliable solutions. The expertise gained in the past decades in mass production for flexible electronics leads to a unique capacity to propose cost-effective complex solutions for medical partners, both for biosensors, design, converting and secured data transfer.

If you wish to discuss with Alix Joseph, New Ventures HealthCare Director at Linxens, do not hesitate to contact us.

Press contact : Agence Elektron

Alicja Prod’homme / +33 6 50 17 54 91 / alicja@elektron-presse.com
Camille Gachet / +33 6 84 34 74 70 / camille@elektron-presse.com

Over the last decade, leveraging on its expertise and know-how, Linxens has developed innovative interface and sensing solutions dedicated to medical care. A committed supplier to Siemens Healthineers Point of Care Business for over 10 years, the biosensor tape that has been exclusively designed for the epoc® Blood Analysis System consumables from Siemens Healthineers has been carefully conceived to perform quick and reliable electrochemical measurement on blood, thanks to Linxens’ unique noble metal plating capabilities.

When the global COVID 19 pandemic peaked last year, Siemens Healthineers saw an increase in demand for their epoc® system which are placed in critical care units and emergency rooms around the world for rapid patient diagnosis. With this increase in demand, the need for consumables also rose and the demand for Linxens’ reel-to-reel biosensors doubled. Facing unprecedented health and safety restrictions, Linxens’ factory in Singapore worked with the local Government to obtain approval to continue manufacturing the reel-to-reel biosensor tape to ensure its supply to Siemens Healthineers.

“Under normal circumstances, our factory runs 24/7 and it’s thanks to the commitment of the Linxens staff, particularly those from Operations, Supply Chain and Purchasing, that we were able to ensure that the teams were in place and safe, and that we had the necessary stock of products to ensure on-time delivery to our client,” adds Velmurugan Ramanathan, Plant Director, Linxens. “I believe that problems are opportunities in disguise, and this was the perfect opportunity to satisfy the needs of Siemens Healthineers during this harsh pandemic.”

Siemens Healthineers knew that it could rely on Linxens’ expertise and agility to accelerate production to meet the surge in demand for biosensor tape to ensure that their consumables, including epoc® systems reached healthcare professionals as quickly as possible.

“Our sites are set-up for mass volume, high-quality component manufacturing in reel-to-reel format. Despite the strict governmental restrictions that were implemented during the peak of the crisis, we received the authorization to open our facility in Singapore and are proud to have been able to double our production to ensure on-time delivery to Siemens Healthineers.” says Arnaud Brunetiere, Chief Operating Officer, Linxens.

Point-of-Care Testing from Siemens Healthineers

Particularly useful since the beginning of last year, the epoc® Blood Analysis System is a handheld, wireless solution to enable comprehensive blood gas, basic metabolic panel, hematocrit and lactate testing at the patient’s side on a single room temperature stable test card, with results in less than a minute after sample introduction.
“In addition to guaranteeing an uninterrupted supply, Linxens assured us of dedicated capacity for patient care. Their team certainly stepped up by meeting a 2x demand surge,” commented Mathias Ganzmann, Vice President, Site Operations, Siemens Healthineers

Download the press release